PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia

María Eva Mingot Castellano; Charlotte A Bradbury; Clara Rosso Fernández; Ian  Thomas; Maria Teresa Alvarez-Román; Mariana Canaro; Isabel Socorro Caparrós Miranda; et al.

doi:10.1097/01.hs9.0000852056.49558.d7

PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia

María Eva Mingot Castellano^*, Charlotte A Bradbury, Clara Rosso Fernández, Ian Thomas, Maria Teresa Alvarez-Román, Mariana Canaro, Isabel Socorro Caparrós Miranda, et al.

^*Corresponding author for this work

Bristol Medical School (THS)

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)

Original language	English
Title of host publication	June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book
Publisher	Wolters Kluwer
Pages	3967-3969
Number of pages	3
Volume	6
Edition	S3
DOIs	https://doi.org/10.1097/01.hs9.0000852056.49558.d7
Publication status	Published - 12 Jun 2022
Event	27th Congress of the European Hematology Association (EHA) 2022 - Hybrid, Vienna, Austria Duration: 9 Jun 2022 → 12 Jun 2022 https://www.vjhemonc.com/event/eha-2022/

Publication series

Name	HemaSphere
Publisher	Wolters Kluwer
ISSN (Electronic)	2572-9241

Conference

Conference	27th Congress of the European Hematology Association (EHA) 2022
Abbreviated title	EHA2022
Country/Territory	Austria
City	Vienna
Period	9/06/22 → 12/06/22
Internet address	https://www.vjhemonc.com/event/eha-2022/

Bibliographical note

Publisher Copyright:
© 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Access to Document

10.1097/01.hs9.0000852056.49558.d7Licence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

Castellano, M. E. M., Bradbury, C. A., Fernández, C. R., Thomas, I., Alvarez-Román, M. T., Canaro, M., Miranda, I. S. C., & al., E. (2022). PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia. In June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book (S3 ed., Vol. 6, pp. 3967-3969). (HemaSphere). Wolters Kluwer. https://doi.org/10.1097/01.hs9.0000852056.49558.d7

Castellano, María Eva Mingot ; Bradbury, Charlotte A ; Fernández, Clara Rosso et al. / PB2307 : A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia. June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book. Vol. 6 S3. ed. Wolters Kluwer, 2022. pp. 3967-3969 (HemaSphere).

@inproceedings{b5d97cf9c5054eb1b82f7b099370775f,

title = "PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia",

author = "Castellano, {Mar{\'i}a Eva Mingot} and Bradbury, {Charlotte A} and Fern{\'a}ndez, {Clara Rosso} and Ian Thomas and Alvarez-Rom{\'a}n, {Maria Teresa} and Mariana Canaro and Miranda, {Isabel Socorro Caparr{\'o}s} and et al.",

note = "Publisher Copyright: {\textcopyright} 2022 the Author(s). Published by Wolters Kluwer Health, Inc.; 27th Congress of the European Hematology Association (EHA) 2022, EHA2022 ; Conference date: 09-06-2022 Through 12-06-2022",

year = "2022",

month = jun,

day = "12",

doi = "10.1097/01.hs9.0000852056.49558.d7",

language = "English",

volume = "6",

series = "HemaSphere",

publisher = "Wolters Kluwer",

pages = "3967--3969",

booktitle = "June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book",

address = "Netherlands",

edition = "S3",

url = "https://www.vjhemonc.com/event/eha-2022/",

}

Castellano, MEM, Bradbury, CA, Fernández, CR, Thomas, I, Alvarez-Román, MT, Canaro, M, Miranda, ISC & al., E 2022, PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia. in June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book. S3 edn, vol. 6, HemaSphere, Wolters Kluwer, pp. 3967-3969, 27th Congress of the European Hematology Association (EHA) 2022, Vienna, Austria, 9/06/22. https://doi.org/10.1097/01.hs9.0000852056.49558.d7

PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia. / Castellano, María Eva Mingot; Bradbury, Charlotte A; Fernández, Clara Rosso et al.
June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book. Vol. 6 S3. ed. Wolters Kluwer, 2022. p. 3967-3969 (HemaSphere).

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)

TY - GEN

T1 - PB2307

T2 - 27th Congress of the European Hematology Association (EHA) 2022

AU - Castellano, María Eva Mingot

AU - Bradbury, Charlotte A

AU - Fernández, Clara Rosso

AU - Thomas, Ian

AU - Alvarez-Román, Maria Teresa

AU - Canaro, Mariana

AU - Miranda, Isabel Socorro Caparrós

AU - al., et

PY - 2022/6/12

Y1 - 2022/6/12

UR - https://www.vjhemonc.com/event/eha-2022/

U2 - 10.1097/01.hs9.0000852056.49558.d7

DO - 10.1097/01.hs9.0000852056.49558.d7

M3 - Conference Contribution (Conference Proceeding)

VL - 6

T3 - HemaSphere

SP - 3967

EP - 3969

BT - June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book

PB - Wolters Kluwer

Y2 - 9 June 2022 through 12 June 2022

ER -

Castellano MEM, Bradbury CA, Fernández CR, Thomas I, Alvarez-Román MT, Canaro M et al. PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia. In June 2022 - Volume 6 - S3, EHA2022 Hybrid Congress Abstract Book. S3 ed. Vol. 6. Wolters Kluwer. 2022. p. 3967-3969. (HemaSphere). doi: 10.1097/01.hs9.0000852056.49558.d7

PB2307: A multicenter, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia

Publication series

Conference

Bibliographical note

Access to Document

Handle.net

Other files and links

Cite this